Tuesday, March 14, 2017 9:22:35 PM
From yahoo board (Brian) - I really hope it is all true
I know it's frustrating, but I had a recent meeting with Katie who provided some information you can find by calling the 30+ clinics now using it that show how the INVOCell is starting to take off like a rocketship. You better lock in your seat belt, load up on shares now and buy on the dips (however they occur) and get ready for takeoff if you believe that this disruptive technology and procedure is going to revolutionize the IVF market by providing IVF at a fraction of the cost when compared to traditional IVF.
A HUGE part of its success is Dr. Doody and Katie who have amazing personalities with doctors recently coming to them by referral and word of mouth to use the INVOCell and its procedure . The clinic in Calgary is planning to open 10 more like it. 100 patients x 10 clinics x $500/Invocell is $500K just from the 10 clinics.. According to this official site, https://www.bls.gov/oes/current/oes291064.htm, there are 20,000 that could administer the INVOCell. So, let's go back to math class again. $500/INVOC Cell x 100 patients per clinic x 20,000 gynecologists = $1,000,000,000. That's $1B company now valued at $20M. That's a 50X multiple to where the stock is right now. If you take into consideration the total shares outstanding (more than just those we know about), maybe we're at 30X multiple. Assume they do half that amount that's a 15X multiple making the stock price around $4. But if they do all of it, that puts the stock at $8 and if there's less stock I suggested even higher.
So with al the hubub, WHY ARE WE AT $0.25. well.... IMO.... All respect to Dr Renauex, but from some clinics I called they told me he was not easy to work with, used an inferior procedure using the INVOCell, and due to poor communication skills left many no longer interested in the INVOCell. When you go to buy a car, if you like the salesperson, you'll likely go for it. It's my impression from those he worked with that he was not a prince charming but more of a negative complainer you don't want to work with. We was fired by Katie. He was one of those people great at being the science behind it, but was horrible at bringing it to market. It is my opinion they it is his fault that this ground breaking disruptive technology has been held back. Even if you have the best idea in the world, you have to bring it to the doctors and prove to them to give up what they're doing. He wasn't good at that . Sorry Dr Renaux, but i don't know you personally and wish you the best of luck but I'm really glad you're out of the picture.
From what it sounds like from Katie, she and Dr Doody are al over the place actively training at least 40+ doctors on this technology and PROCEDURE with higher than average success in some of their top clinics and of course over 80% success in Texas. NOTE: It's not just the INVOCell that will make this a homerun. It's the procedure used with the INVOCEll that makes this a huge success.
I asked Katie why haven't we seen these numbers for the 30 clinics. She said that she can't until the financials are released. She's been very frustrated with the fact that others in charge of the financials can't seem to get them done. This is not another Dr. Renaeux scenario, but someone that's taking longer than expected. All that appear to be behind us as she reassured me that by the end of the month the financial through 2015 will be made available and soon thereafter 2016 with all the details of clinics using it and units sold. Although she was eager to get them pubnlished too, I'm still not confident that they may be ready. That is the strange part, but from what I can see by the number of clinics active and hearing about some asking for refills of the INVOCell that this will take off.
I must've mentioned how important it is to get the financials done in our conversation a million times. She knows it. Now they just need to get it done. It appears to be quick a process and with only one person doing it, this is they way it will be.
Of course, once the financial come, financing can be done to hire a new CEO later in the year followed by a Sales and Marketing Director to go to market and really expand in force. They just don't have the money or time to do that now. They're too busy training those using it and are waiting for its success to help move it to the next level.
Wow! This was a long one. but my point is, I'm a believer. The price will suffer int he immediate term, but IMO by the end of this year we'll be looking back at this and laughing how silly it was for us to worry. The ultimate would be some sort of buyout. She didn't mention any likely buyers. But I'm thinking who would be the best to get the INVOCell out itself? I asked Katie that question but didn't have any answers. Not sure who would buy them, but hopefully someone in the market who could quickly infuse the INVOCell and its procedure into the traditional IVF market quickly to many at once. I was thinking since the procedure still requires some IVF stimulation, then what about an IVF drug company that could do this I wonder? Or Medical Device Companies that would do this?
Recent INVO News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 08:05:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2024 09:21:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:06:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 01:00:36 PM
- INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA • GlobeNewswire Inc. • 08/14/2024 01:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/21/2024 08:39:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:51:16 PM
- INVO Reports Record First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/15/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:30:18 PM
- Micro Cap Massively Bid Up Before Opening Bell • AllPennyStocks.com • 04/17/2024 02:25:00 PM
- INVO Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 04/16/2024 08:59:29 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 03:24:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 02:01:07 PM
- NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON) • GlobeNewswire Inc. • 01/23/2024 01:00:00 PM
- INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors • GlobeNewswire Inc. • 01/17/2024 01:00:00 PM
- Form S-4 - Registration of securities, business combinations • Edgar (US Regulatory) • 01/16/2024 10:29:59 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/10/2024 09:46:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 09:05:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:29:45 PM
- Form 424B7 - Prospectus [Rule 424(b)(7)] • Edgar (US Regulatory) • 12/28/2023 10:04:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 10:02:41 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/13/2023 10:08:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 09:53:21 PM
- NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology's Blood Journal • PR Newswire (US) • 12/11/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 10:18:38 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM